With a strong team of scientists, veterinarians, nutritionists and doctors, probiotic research sits at the heart of what we do at ADM Protexin. Together the research team work to better understand the characteristics of the live microorganisms used in our products. We achieve this though a combination of pre-clinical research in-vitro - conducted in our laboratories in the UK and Spain - as well as through our innovative clinical-stage research programme.
We run an extensive research programme to further build our knowledge of how these products and the microorganisms in them can affect the health of diverse populations, both human and animal.
Our drive for excellence in probiotic research provides our customers with the most effective products in gut health.
Our first step is to analyse the genetic blueprint of each of the bacterial strains; we do this by sequencing their DNA, meaning we are able to identify each and every nucleotide - the building blocks of DNA - found in our bacteria.
We can then start to understand the characteristics and functionality of each strain, answering questions like: how well does a particular bacterium survive in a given environment; which short-chain fatty acids do our strains produce; or even which neurotransmitters are they capable of making.
Understanding these functionalities in the lab is just the beginning. The Protexin range is also supported by an extensive library of scientific publications. These have been conducted with universities and research groups both in the UK and around the world.
There has certainly been an influx of probiotic products on the market over the last 5-10 years and with over 21,000 research articles on probiotics listed on PubMed, we undoubtedly seem to be in a gut era.
These probiotic products take on a range of forms from yoghurt drinks, oat based products and chocolate to dietary supplements presented in capsules, tablets, liquid or powder form. With all these different variations it is hard to know which product to choose without knowing more in depth information about the product and the company behind it.
Probiotic trials now being published are of good quality and have convincing results with much more of the work being done in digestive disorders, immune response and pathogen inhibition. However, there is other work that also looks promising in the field of (amongst others) cancer prevention, obesity and autism.
This booklet provides an insight into ADM Protexin and an update on research carried out to date.
READ OUR PROBIOTIC RESEARCH
